Zanamivir controlled release - Ala Wai Pharma

Drug Profile

Zanamivir controlled release - Ala Wai Pharma

Alternative Names: AWP 09VDB S; Zanamivir gastric resistant - Ala Wai Pharma

Latest Information Update: 02 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ala Wai Pharma
  • Class Antivirals; Guanidines; Pyrans; Sialic acids
  • Mechanism of Action Neuraminidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I Influenza virus infections

Most Recent Events

  • 02 Aug 2017 Chemical structure information added
  • 18 Oct 2016 Phase-I clinical trials in Influenza virus infections (In volunteers) in Australia (PO) (ACTRN12616001475437)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top